Status:

ACTIVE_NOT_RECRUITING

App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Metastatic Renal Cell Carcinoma

Stage IV Renal Cell Cancer AJCC v8

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This trial tests the feasibility of an application (app)-based mindfulness intervention and its effect on improving quality of life in patients with renal cell cancer that has spread to other places i...

Detailed Description

PRIMARY OBJECTIVES: I. To assess feasibility of the Am mindfulness app in metastatic renal cell carcinoma (mRCC) patients, with respect to accrual, adherence and engagement in program. II. To assess...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Sufficiently fluent in English
  • Cytologically or pathologically verified diagnosis of renal cell carcinoma (RCC)
  • Evidence of metastatic disease (including at a minimum computed tomography \[CT\] of the chest, abdomen and pelvis for staging)
  • Undergoing immunotherapy
  • A "moderate" or greater fear of cancer progression, as demonstrated by an Fear of Cancer Recurrence-7 (FCR-7) score of \>= 17
  • A fear of cancer progression, as demonstrated by a Patient Reported Outcomes Measurement Information System (PROMIS)-Anxiety score \>= 13
  • Have smart phone with internet access
  • Not suffering from current major depressive disorder, bipolar disorder or other psychiatric disorder
  • Not currently engaging in meditation one or more times per week within the previous year
  • Has not participated in an mindfulness-based cancer recovery (MBCR) or mindfulness-based stress reduction (MBSR) program in the past 5 years

Exclusion

    Key Trial Info

    Start Date :

    August 23 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 30 2025

    Estimated Enrollment :

    21 Patients enrolled

    Trial Details

    Trial ID

    NCT04788095

    Start Date

    August 23 2021

    End Date

    December 30 2025

    Last Update

    July 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    City of Hope Medical Center

    Duarte, California, United States, 91010